|
Volumn 52, Issue 3, 2004, Pages 199-203
|
The clinical efficacy of Bladder Chek NMP22 in urothelial cancer
a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
NUCLEAR MATRIX PROTEIN 22;
NUCLEAR PROTEIN;
TUMOR MARKER;
ARTICLE;
BLADDER TUMOR;
CANCER STAGING;
COMPARATIVE STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
EVALUATION;
HUMAN;
LABORATORY DIAGNOSIS;
MASS SCREENING;
METHODOLOGY;
PATHOLOGY;
SENSITIVITY AND SPECIFICITY;
URETER TUMOR;
URINE;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FALSE POSITIVE REACTIONS;
HUMANS;
MASS SCREENING;
NEOPLASM STAGING;
NUCLEAR PROTEINS;
SENSITIVITY AND SPECIFICITY;
TUMOR MARKERS, BIOLOGICAL;
URETERAL NEOPLASMS;
URINARY BLADDER NEOPLASMS;
|
EID: 3042576463
PISSN: 00471860
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (0)
|